muscle loss glp-1 Some people taking weight drugs are concerned about loss. In general, people with obesity have more muscle mass than people without obesity — simply because their bodies have to Semaglutide (GLP-1) Muscle Loss: Body

(NASDAQ:WGRX) (Wellgistics) , a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx into its patented blockchain-enabled smart contracts platform PharmacyChain , today announced the launch of medical food Forzet for the dietary management of muscle loss associated with weight loss therapies

We dont have any evidence that low-dose, intermittent use of GLP-1s provides meaningful or sustained weight loss or broader health benefits

causation has not been shown

A.KoltermanO

ATTAIN-1 (NCT05869903) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron at various doses to placebo in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes